0.00Open0.00Pre Close0 Volume0 Open Interest61.00Strike Price0.00Turnover781.13%IV-23.64%PremiumDec 27, 2024Expiry Date18.89Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9693Delta0.0058Gamma4.19Leverage Ratio-2.9222Theta0.0002Rho4.06Eff Leverage0.0011Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet